159 related articles for article (PubMed ID: 12557227)
21. TGFbeta1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps.
Sparks R; Bigler J; Sibert JG; Potter JD; Yasui Y; Ulrich CM
Int J Epidemiol; 2004 Oct; 33(5):955-61. PubMed ID: 15020570
[TBL] [Abstract][Full Text] [Related]
22. Exclusion of Madh2, Madh4, and Madh7 as candidates for the modifier of Min 2 (Mom2) locus.
Silverman KA; Koratkar RA; Siracusa LD; Buchberg AM
Mamm Genome; 2003 Feb; 14(2):119-29. PubMed ID: 12584607
[TBL] [Abstract][Full Text] [Related]
23. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice.
Xu X; Brodie SG; Yang X; Im YH; Parks WT; Chen L; Zhou YX; Weinstein M; Kim SJ; Deng CX
Oncogene; 2000 Apr; 19(15):1868-74. PubMed ID: 10773876
[TBL] [Abstract][Full Text] [Related]
24. Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer.
Maliekal TT; Antony ML; Nair A; Paulmurugan R; Karunagaran D
Oncogene; 2003 Jul; 22(31):4889-97. PubMed ID: 12894231
[TBL] [Abstract][Full Text] [Related]
25. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
Jazag A; Ijichi H; Kanai F; Imamura T; Guleng B; Ohta M; Imamura J; Tanaka Y; Tateishi K; Ikenoue T; Kawakami T; Arakawa Y; Miyagishi M; Taira K; Kawabe T; Omata M
Oncogene; 2005 Jan; 24(4):662-71. PubMed ID: 15592526
[TBL] [Abstract][Full Text] [Related]
26. Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta.
Ijichi H; Otsuka M; Tateishi K; Ikenoue T; Kawakami T; Kanai F; Arakawa Y; Seki N; Shimizu K; Miyazono K; Kawabe T; Omata M
Oncogene; 2004 Feb; 23(5):1043-51. PubMed ID: 14762439
[TBL] [Abstract][Full Text] [Related]
27. Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps.
Messick CA; Church J; Casey G; Kalady MF
Dis Colon Rectum; 2009 Sep; 52(9):1535-41. PubMed ID: 19690479
[TBL] [Abstract][Full Text] [Related]
28. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
Crabtree M; Sieber OM; Lipton L; Hodgson SV; Lamlum H; Thomas HJ; Neale K; Phillips RK; Heinimann K; Tomlinson IP
Oncogene; 2003 Jul; 22(27):4257-65. PubMed ID: 12833148
[TBL] [Abstract][Full Text] [Related]
29. Germline mutations of the MYH gene in Japanese patients with multiple colorectal adenomas.
Miyaki M; Iijima T; Yamaguchi T; Hishima T; Tamura K; Utsunomiya J; Mori T
Mutat Res; 2005 Oct; 578(1-2):430-3. PubMed ID: 15890374
[TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal tumorigenesis in Smad4 (Dpc4) mutant mice.
Taketo MM; Takaku K
Hum Cell; 2000 Sep; 13(3):85-95. PubMed ID: 11197776
[TBL] [Abstract][Full Text] [Related]
31. Mutation of acceptor splice site of the SEDL gene in X-linked spondyloepiphyseal dysplasia tarda causes the activation of cryptic splice site.
Ma HW; Jiang J; Lu JF; Guo R; Niu GH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):251-3. PubMed ID: 15952107
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of SMAD4 mutations and protein expression in juvenile polyposis: evidence for a distinct genetic pathway and polyp morphology in SMAD4 mutation carriers.
Woodford-Richens KL; Rowan AJ; Poulsom R; Bevan S; Salovaara R; Aaltonen LA; Houlston RS; Wright NA; Tomlinson IP
Am J Pathol; 2001 Oct; 159(4):1293-300. PubMed ID: 11583957
[TBL] [Abstract][Full Text] [Related]
33. [Colorectal serrated adenoma: diagnostic criteria and clinical implications].
Rüschoff J; Aust D; Hartmann A
Verh Dtsch Ges Pathol; 2007; 91():119-25. PubMed ID: 18314605
[TBL] [Abstract][Full Text] [Related]
34. Smad4 deficiency in cervical carcinoma cells.
Baldus SE; Schwarz E; Lohrey C; Zapatka M; Landsberg S; Hahn SA; Schmidt D; Dienes HP; Schmiegel WH; Schwarte-Waldhoff I
Oncogene; 2005 Jan; 24(5):810-9. PubMed ID: 15531914
[TBL] [Abstract][Full Text] [Related]
35. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
36. Novel de novo mutation of MADH4/SMAD4 in a patient with juvenile polyposis.
Burger B; Uhlhaas S; Mangold E; Propping P; Friedl W; Jenne D; Dockter G; Back W
Am J Med Genet; 2002 Jul; 110(3):289-91. PubMed ID: 12116240
[No Abstract] [Full Text] [Related]
37. Differential expression of Rac1 identifies its target genes and its contribution to progression of colorectal cancer.
Gómez del Pulgar T; Bandrés E; Espina C; Valdés-Mora F; Pérez-Palacios R; García-Amigot F; García-Foncillas J; Lacal JC
Int J Biochem Cell Biol; 2007; 39(12):2289-302. PubMed ID: 17766170
[TBL] [Abstract][Full Text] [Related]
38. Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis.
Inoue H; Furukawa T; Sunamura M; Takeda K; Matsuno S; Horii A
Genes Chromosomes Cancer; 2001 Jul; 31(3):295-9. PubMed ID: 11391801
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients.
Koyama M; Ito M; Nagai H; Emi M; Moriyama Y
Mutat Res; 1999 Aug; 406(2-4):71-7. PubMed ID: 10479724
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
